PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
PROCEPt BioRobotics公布强劲的第三季度收益,加入Monte Rosa Therapeutics、eyepoint pharmaceuticals和其他大型股票周一走高
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Monday.
美国股市上涨,道琼斯指数周一上涨约200点。
Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) rose sharply during Monday's session after the company reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance.
Procept BioRobotics Corporation(纳斯达克股票代码:PRCT)的股价在周一的交易中大幅上涨,此前该公司公布的第三季度财务业绩好于预期,并上调了24财年的收入预期。
PROCEPT BioRobotics shares jumped 25% to $85.87 on Monday.
周一,Procept BioRobotics的股价上涨了25%,至85.87美元。
Here are some other big stocks recording gains in today's session.
以下是今天交易日其他一些上涨的大型股票。
- Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) shares jumped 60.5% to $7.85 after the company announced a global license agreement with Novartis to advance VAV1 MGDs. The company will receive a $150 million upfront payment and is eligible for additional milestone payments.
- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) gained 33.6% to $12.69 after the company showed early trial data for DURAVYU for diabetic macular edema and announced improving vision and anatomy.
- Revance Therapeutics, Inc. (NASDAQ:RVNC) shares gained 25.5% to $5.89 after the company announced it entered into the sixth amendment to its exclusive distribution agreement with Teoxane.
- ImmunityBio, Inc. (NASDAQ:IBRX) gained 19.5% to $6.36.
- Trump Media & Technology Group Corp. (NASDAQ:DJT) rose 15.3% to $44.91. The stock may be moving amid possible volatility as traders evaluate his chance of winning the 2024 presidential election.
- Prothena Corporation plc (NASDAQ:PRTA) surged 15.3% to $17.66.
- Serve Robotics Inc. (NASDAQ:SERV) gained 13.8% to $11.09. Ladenburg Thalmann analyst Glenn Mattson initiated coverage on Serve Robotics with a Buy rating and announced a price target of $16.
- Vera Therapeutics, Inc. (NASDAQ:VERA) rose 12.1% to $46.05 after the company reported 96-week eGFR stabilization on Saturday for its Phase 2b study of IgAN patients with Atacicept.
- MINISO Group Holding Limited (NASDAQ:MNSO) gained 10.3% to $19.21.
- TeraWulf Inc. (NASDAQ:WULF) rose 10.2% to $7.03.
- WeRide Inc. (NASDAQ:WRD) gained 9% to $18.03.
- Newell Brands Inc. (NASDAQ:NWL) rose 8.3% to $9.45. Canaccord Genuity analyst Brian McNamara maintained Newell Brands with a Buy and raised the price target from $12 to $13.
- MicroStrategy Incorporated (NASDAQ:MSTR) gained 7% to $251.00 amid a rise in Bitcoin.
- MARA Holdings, Inc. (NASDAQ:MARA) rose 6.3% to $18.14 amid a rise in Bitcoin.
- 蒙特罗莎疗法公司(纳斯达克股票代码:GLUE)股价上涨60.5%,至7.85美元,此前该公司宣布与诺华签订全球许可协议,以推进VAV1 MGD的发展。该公司将获得1.5亿美元的预付款,并有资格获得额外的里程碑付款。
- EyePoint制药公司(纳斯达克股票代码:EYPT)上涨33.6%,至12.69美元,此前该公司公布了DURAVYU治疗糖尿病黄斑水肿的早期试验数据,并宣布改善视力和解剖结构。
- Revance Therapeutics, Inc.(纳斯达克股票代码:RVNC)的股价上涨25.5%,至5.89美元,此前该公司宣布与Teoxane签订了独家分销协议的第六次修正案。
- ImmunityBio, Inc.(纳斯达克股票代码:IBRX)上涨19.5%,至6.36美元。
- 特朗普媒体与科技集团公司(纳斯达克股票代码:DJT)上涨15.3%,至44.91美元。随着交易员评估他赢得2024年总统大选的机会,该股可能会在可能的波动中波动。
- Prothena Corporation plc(纳斯达克股票代码:PRTA)上涨15.3%,至17.66美元。
- Serve Robotics Inc.(纳斯达克股票代码:SERV)上涨13.8%,至11.09美元。拉登堡塔尔曼分析师格伦·马特森以买入评级启动了对Serve Robotics的报道,并宣布目标股价为16美元。
- Vera Therapeutics, Inc.(纳斯达克股票代码:VERA)上涨12.1%,至46.05美元,此前该公司周六报告其针对IgAn患者的Atacicept患者的20年期研究为期96周的表皮生长因子保持稳定。
- 名创集团控股有限公司(纳斯达克股票代码:MNSO)上涨10.3%,至19.21美元。
- TeraWulf Inc.(纳斯达克股票代码:WULF)上涨10.2%,至7.03美元。
- WeRide Inc.(纳斯达克股票代码:WRD)上涨9%,至18.03美元。
- 纽厄尔品牌公司(纳斯达克股票代码:NWL)上涨8.3%,至9.45美元。Canaccord Genuity分析师布莱恩·麦克纳马拉维持纽厄尔品牌的买入并将目标股价从12美元上调至13美元。
- 在比特币上涨的背景下,微策略公司(纳斯达克股票代码:MSTR)上涨7%,至251.00美元。
- 在比特币上涨的情况下,玛拉控股公司(纳斯达克股票代码:MARA)上涨6.3%,至18.14美元。
Now Read This:
现在读这个:
- Top 3 Real Estate Stocks That May Surge In Q4
- 第四季度可能飙升的三大房地产股